Abstract

Circulating tumor DNA (ctDNA) is a promising resource to detect and monitor molecular characteristics of tumors. In the present study, we precisely determined mutational status of plasma ctDNA in patients with genitourinary (GU) cancers.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call